Tags |
|
|
Links |
|
|
Digg It - Poor Performers - Why Feedback Doesn't Work
Research undertaken in the late 90’s discovered that 360 degree feedback had more impact on below-average performers but that the worst of performers rarely
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
changed as a result of feedback. Why is this the case? Personal Construct Psychology (PCP) provides some insight.
They have fixed perceptions of themse
They have fixed perceptions of themse
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ves
PCP suggests that self perceptions don’t exist in isolation but are linked in elaborate networks. Some of our perceptions are core and explain how
PCP suggests that self perceptions don’t exist in isolation but are linked in elaborate networks. Some of our perceptions are core and explain how
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
e see ourselves. Not surprisingly, core self perceptions are difficult to change – so many other beliefs about ourselves depend on them. The worst of perfo
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
rmers are those who have been in their job for a long time but failed to change with the times. They have fixed perceptions of their job which are loosely l
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
nked to how they see themselves. Feedback which questions their performance in the job therefore questions their core self perceptions. This is difficult f
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
r an individual to take on board and even more difficult to get them to change their behaviour.
They have previously been given positive feedback
Re
They have previously been given positive feedback
Re
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
searchers at Duke University recently discovered that resistance to change may often stem from an individual’s failure to absorb and process negative feedbac
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
about a project when they had previously received positive or encouraging feedback about a project’s potential. Earlier positive feedback caused the indivi
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
uals to distort or give less weight to the negative information which came along later on. The same could be said of feedback. If an organization has not b
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
en honest with an underperformer over the years, it will be nearly impossible to ‘correct’ an individual’s perception.
They are expected to understand an
They are expected to understand an
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
d believe the feedback
Giving feedback, particularly critical feedback, can be difficult and awkward. When done badly it can have a long term negative
Giving feedback, particularly critical feedback, can be difficult and awkward. When done badly it can have a long term negative
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
mpact on an individual’s motivation. Line managers, armed with this knowledge, often feel the need to ‘dump’ feedback on an individual, without helping them
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
to understand and interpret the feedback for themselves. Only an individual can confirm or disconfirm their own perceptions; others can’t do it for them. C
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
hances are that if you find yourself explaining or telling an individual what their feedback means, you will get little or no change in perception or perform
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
nce.
What to do:
What to do:
- Explore the role first:
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ividual’s role, performance and concerns. Understanding the individual’s perceptions of the role and where they feel they may be underperforming will help p
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
rioritise the feedback.
Get them to come up with the answer:
Encourage the individual to work out what the feedback means for themselves.
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
et them to focus on just a few strengths or weaknesses. Facilitate a discussion rather than tell them the answer.
Be honest:
Be honest and
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
consistent with the feedback. Review previous feedback forms to understand what has come before and build on earlier messages using the same language.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/22527/diggit-Poor-Performers--Why-Feedback-Doesnt-Work.html">Poor Performers - Why Feedback Doesn't Work</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/22527/diggit-Poor-Performers--Why-Feedback-Doesnt-Work.html]Poor Performers - Why Feedback Doesn't Work[/url]
Related Articles:
Workplace Violence - Acknowledge, Anticipate, and Act
Using Flyers to Advertise Your Online Business
There Is No Huge Correlation Between Education and Income and Here Is Why - Part 2
Bookmark it:
|